SCHEMBL21769288

SCHEMBL21769288

NC(=O)CC[C@H](NC(=O)CNC(=O)CCc1ccc(O)cc1)C(=O)NCC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIA1 P42261 1/20 0.44
▸ F2 P00734 1/20 0.42
▸ OPRD1 P41143 5/20 0.41
▸ OPRM1 P35372 4/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ SLC6A9 P48067 1/20 0.40
▸ SLC6A5 Q9Y345 1/20 0.40
▸ MMP2 P08253 2/20 0.39
▸ MMP8 P22894 2/20 0.39
▸ MMP12 P39900 2/20 0.39
▸ MMP13 P45452 2/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ MMP10 P09238 1/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP14 P50281 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ CD40 P25942 1/20 0.39
▸ GLO1 Q04760 1/20 0.39
▸ NAALAD2 Q9Y3Q0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21769209 1.00 GRIA1 (0.44) GRIA1F2OPRD1OPRM1OPRK1
SCHEMBL29448567 0.86 OPRD1 (0.55) OPRD1OPRM1OPRK1
SCHEMBL16385079 0.86 NPY4R (0.51) OPRD1OPRM1OPRK1MMP8NPY1R
SCHEMBL16384720 0.86 NPY4R (0.51) OPRD1OPRM1OPRK1MMP8NPY1R
SCHEMBL29591811 0.82 OPRD1 (0.52) OPRD1OPRM1OPRK1CD40
SCHEMBL30468670 0.81 CHRND (0.47) GRIA1NAALAD2NPY1R
SCHEMBL29707530 0.81 CHRND (0.47) GRIA1NAALAD2NPY1R
SCHEMBL29590322 0.79 OPRD1 (0.57) OPRD1OPRM1OPRK1APC
SCHEMBL1221588 0.79 HDAC2 (0.57) KDM4EHDAC2HDAC8
SCHEMBL15186015 0.78 MMP2 (0.52) GRIA1MMP2MMP8MMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3613755-A1 LYSINE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS USING MICROBIAL TRANSGLUTAMINASE Novartis AG (CH) 2020-02-26 — — EP disclosed
Send feedback